首页> 外国专利> Method of manufacturing sustained release microbeads containing venlafaxine HCL

Method of manufacturing sustained release microbeads containing venlafaxine HCL

机译:含有文拉法辛盐酸盐的缓释微珠的制备方法

摘要

A sustained release Venlafaxine composition that includes a plurality of non-agglomerated, uniformly-shaped and sized microbeads of inert core particles having a first coating layer. The first coating layer includes an active agent of Venlafaxine or a pharmaceutical acceptable salt thereof, a binder, and an anti-tack agent. The active agent is present in the first coating layer in a concentration of at least about 5% to about 70% by weight of the composition, the binder is present in an amount of at least 35% by weight of the active agent, or in a further layer located upon or below the first coating layer, or as an alternating layer between plural first layers, wherein the binder is present in an amount of less than about 2.5% by weight of the composition, and the anti-tack agent is present in the first coating layer in a concentration of about 2.5% to about 20% by weight based on the weight of the active agent. The composition is also substantially free of organic acid.
机译:缓释文拉法辛组合物,其包含多个具有第一包衣层的惰性芯颗粒的非团聚,均匀形状和大小的微珠。第一涂层包括文拉法辛的活性剂或其药学上可接受的盐,粘合剂和抗粘剂。活性剂在第一涂层中的存在浓度为组合物重量的至少约5%至约70%,粘合剂的存在量为活性剂的至少35%重量,或位于第一涂层之上或之下的另一层,或作为多个第一层之间的交替层,其中粘合剂的存在量小于组合物重量的约2.5%,并且存在抗粘剂以活性剂的重量为基准计,第一涂层中的维生素A的浓度为约2.5重量%至约20重量%。该组合物也基本上不含有机酸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号